VDUP1 upregulated by TGF-β1 and 1,25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression

被引:237
作者
Han, SH
Jeon, JH
Ju, HR
Jung, U
Kim, KY
Sook, H
Yoo, HS
Lee, YH
Song, KS
Hwang, HM
Na, YS
Yang, Y
Lee, KN
Choi, I [1 ]
机构
[1] Korea Res Inst Biosci & Biotechnol, Immunol Lab, Taejon 305333, South Korea
[2] Korea Res Inst Biosci & Biotechnol, Genome Res Ctr, Taejon 305333, South Korea
[3] Chungnam Natl Univ, Coll Med, Dept Pathol, Dept Anat, Taejon 301131, South Korea
基金
新加坡国家研究基金会;
关键词
VDUP1; tumor; TGF-beta; 1; cell cycle; PLZF;
D O I
10.1038/sj.onc.1206610
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vitamin D-3 upregulated protein 1 (VDUP1) is a 1,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3) upregulated protein, and it is induced by various stresses. In human tumor tissues, VDUP1 expression was downregulated. Upon stimulation by growth-inhibitory signals such as TGF-beta1 and 1,25(OH)(2)D-3, its expression was rapidly upregulated as the cell growth was retarded. The transfection of VDUP1 in tumor cells reduced cell growth. The VDUP1 expression was also increased when the cell-cycle progression was arrested. Transfection of VDUP1 induced cell-cycle arrest at the G0/G1 phase, indicating that VDUP1 possesses a tumor-suppressive activity. In addition, it was found that VDUP1 interacted with promyelocytic leukemia zinc-finger, Fanconi anemia zinc-finger, and histone deacetylase 1, which are known to be transcriptional corepressors. VDUP1 itself suppressed IL-3 receptor and cyclin A2 promoter activity. Taken together, these results suggest that VDUP1 is a novel antitumor gene which forms a transcriptional repressor complex.
引用
收藏
页码:4035 / 4046
页数:12
相关论文
共 38 条
[1]  
BANERJEE D, 1995, CELL GROWTH DIFFER, V6, P1405
[2]   Modulation of p53, WAF1/p21 and BCL-2 expression during retinoic acid-induced differentiation of NB4 promyelocytic cells [J].
Bocchia, M ;
Xu, Q ;
Wesley, U ;
Xu, Y ;
Korontsvit, T ;
Loganzo, F ;
Albino, AP ;
Scheinberg, DA .
LEUKEMIA RESEARCH, 1997, 21 (05) :439-447
[3]   The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin [J].
Butler, LM ;
Zhou, XB ;
Xu, WS ;
Scher, HI ;
Rifkind, RA ;
Marks, PA ;
Richon, VM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) :11700-11705
[4]   ISOLATION AND CHARACTERIZATION OF A NOVEL CDNA FROM HL-60 CELLS TREATED WITH 1,25-DIHYDROXYVITAMIN D-3 [J].
CHEN, KS ;
DELUCA, HF .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1994, 1219 (01) :26-32
[5]   Derangement of growth and differentiation control in oncogenesis [J].
Corn, PG ;
El-Deiry, WS .
BIOESSAYS, 2002, 24 (01) :83-90
[6]   The role of promyelocytic leukemia zinc finger and promyelocytic leukemia in leukemogenesis and development [J].
Costoya, JA ;
Pandolfi, PP .
CURRENT OPINION IN HEMATOLOGY, 2001, 8 (04) :212-217
[7]   Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein [J].
David, G ;
Alland, L ;
Hong, SH ;
Wong, CW ;
DePinho, RA ;
Dejean, A .
ONCOGENE, 1998, 16 (19) :2549-2556
[8]   A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF [J].
Hoatlin, ME ;
Zhi, Y ;
Ball, H ;
Silvey, K ;
Melnick, A ;
Stone, S ;
Arai, S ;
Hawe, N ;
Owen, G ;
Zelent, A ;
Licht, JD .
BLOOD, 1999, 94 (11) :3737-3747
[9]   Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function [J].
Junn, E ;
Han, SH ;
Im, JY ;
Yang, Y ;
Cho, EW ;
Um, HD ;
Kim, DK ;
Lee, KW ;
Han, PL ;
Rhee, SG ;
Choi, I .
JOURNAL OF IMMUNOLOGY, 2000, 164 (12) :6287-6295
[10]   Death-defying pathways linking cell cycle and apoptosis [J].
Kirshenbaum, LA .
CIRCULATION RESEARCH, 2001, 88 (10) :978-980